Clinical Program Partnering Leads to Regulatory Approval for Retina Drug

Clinical Program Partnering Leads to Regulatory Approval for Retina Drug
Publish Date:
April 22, 2015

How could a small biotech take its lead compound all the way to regulatory approval with limited resources?

Chiltern managed the full clinical development program — over 15 projects tailored to the sponsor’s needs — including acting as the FDA-facing statistician and overseeing inspection readiness on the way to marketing authorization.